The Move to Bundled Payments Will Be Paradigm-Changing

Article

As with any legislation, there are both positive and negative aspects. Specific to oncology, one of the greatest impacts of the ACA will be the move to a bundled payment for a treatment of a disease.

Bruce Minsky, MD

It is difficult to comment on the full impact of the Affordable Care Act (ACA), since it is complex and how each provision will impact each component of health care is still not fully understood. As with any legislation, there are both positive and negative aspects.

Specific to oncology, one of the greatest impacts of the ACA will be the move to a bundled payment for a treatment of a disease. This will refocus the question in multidisciplinary tumor boards from “what is the ideal way to stage, treat, and manage the patient” to “what is the ideal way to stage, treat, and manage the patient within the reimbursement envelope for their disease.”  The ultimate impact of these 7 paradigm-changing words remains to be determined.

More on the Supreme Court Decision

Derek Raghavan
Bruce Minsky
Nora Janjan
Michael Glod
James B. Yu
Lawrence Wagman
Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content